Genvoya® Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide 150 mg - 150 mg - 200 mg - 10 mg Tablet 30 Tablets

Name: HIV Integrase Inhibitor
Brand: Genvoya®

GENVOYA, TAB 150-200-10MG (30/BT)

McKesson #

1009553

Manufacturer #

61958190101

Brand

Genvoya®

Manufacturer

Gilead Sciences Inc

Country of Origin

Unknown

Alternate Manufacturer Number

3494812

Application

HIV Integrase Inhibitor

Buy American Act (BAA) Compliant

Container Type

Bottle

Dosage Form

Tablet

Generic Drug Code

40092

Generic Drug Name

Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide

NDC Number

61958190101

Product Dating

McKesson Acceptable Dating: we will ship >= 90 days

Quantity

30 Tablets

Strength

150 mg - 150 mg - 200 mg - 10 mg

Trade Agreement Act (TAA) Compliant

Yes

UNSPSC Code

51343808

GENVOYA is indicated as a complete regimen for the treatment of HIV-1 infection in patients 12 years and older (≥35 kg) who have no antiretroviral (ARV) treatment history or to replace the current ARV regimen in patients who are virologically-suppressed (HIV-1 RNA <50 copies/mL) on a stable ARV regimen for ≥6 months with no history of treatment failure and no known resistance to any component of GENVOYA
The tablets are green, capsule-shaped, film-coated tablets, debossed with “GSI%XE2%X80? on one side of the tablet and the number “510%XE2%X80? on the other side of the tablet
Film Coated